Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 118
Usage 2024
Downloads: 3,978,337
Altmetric mentions: 1,452
Articles
Page 155 of 159
-
Citation: Arthritis Research & Therapy 2000 3:66827
-
HCgp-39 positive monocytes in peripheral blood and synovium
Citation: Arthritis Research & Therapy 2000 3:66826 -
Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs
Nonsteroidal anti-inflammatory drugs (NSAIDs) belong to the most frequently used drugs. The discovery of an inducible isoform of cyclo-oxygenase (COX-2) has led to an intensive worldwide search and the introdu...
Citation: Arthritis Research & Therapy 2000 2:379 -
Macrophage derived cytokine and nuclear factor ?B in patients with psoriatic arthritis
Citation: Arthritis Research & Therapy 2000 3:66825 -
zTNF4 blockade in murine lupus
Citation: Arthritis Research & Therapy 2000 3:66824 -
Cell-cell interactions in synovitis Interactions between T lymphocytes and synovial cells
Mechanisms whereby T lymphocytes contribute to synovial inflammation in rheumatoid arthritis are poorly understood. Here we review data that indicate an important role for cell contact between synovial T cells...
Citation: Arthritis Research & Therapy 2000 2:374 -
Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods
The antigenic specificity of an unusual antinuclear antibody pattern in three patient sera was identified after separating HeLa-cell nuclear extracts by two-dimensional (2D) gel electrophoresis and localizing ...
Citation: Arthritis Research & Therapy 2000 2:407 -
The American Fibromyalgia Syndrome Association, Inc
Citation: Arthritis Research & Therapy 2000 2:0014 -
Cytokine, activation marker, and chemokine receptor expression by individual CD4+ memory T cells in rheumatoid arthritis synovium
IL-10, IL-13, IFN-γ, tumor necrosis factor (TNF)-α, LT-α, CD154, and TNF-related activation-induced cytokine (TRANCE) were expressed by 2-20% of rheumatoid arthritis (RA) synovial tissue CD4+ memory T cells, wher...
Citation: Arthritis Research & Therapy 2000 2:415 -
The role of X-chromosome inactivation in female predisposition to autoimmunity
We propose that the phenomenon of X-chromosome inactivation in females may constitute a risk factor for loss of T-cell tolerance; specifically that skewed X-chromosome inactivation in the thymus may lead to in...
Citation: Arthritis Research & Therapy 2000 2:399 -
Ninth Asia Pacific League Of Associations For Rheumatology (APLAR) Congress, Beijing, China, 21-26 May, 2000
The Congress covered the broad field of rheumatology, with participants from China, the Asia Pacific League of Associations for Rheumatology (APLAR) region and the rest of the world. The programme consisted of...
Citation: Arthritis Research & Therapy 2000 2:395 -
Endothelial cells and immune cell migration
Leukocyte ingress into the synovium is a key process in the pathogenesis of rheumatoid arthritis and other inflammatory conditions. In this review, the role of endothelial cells in leukocyte extravasation will...
Citation: Arthritis Research & Therapy 2000 2:368 -
Peptide inhibition of a cytokine response
Citation: Arthritis Research & Therapy 2000 3:66823 -
VEGF production is induced by ligation of CD40
Citation: Arthritis Research & Therapy 2000 3:66822 -
Where is biological therapy going?
The substantial progress in our understanding of molecular and cellular biology has allowed us to design biological therapeutics ('biologicals') with defined targets and effector functions. These biologicals h...
Citation: Arthritis Research & Therapy 2000 2:337 -
Fibroblast biology Effector signals released by the synovial fibroblast in arthritis
There is mounting evidence indicating that the synovial fibroblast is a direct effector of tissue injury and matrix remodeling in inflammatory synovitis. Through the elaboration of effector signals including c...
Citation: Arthritis Research & Therapy 2000 2:356 -
SLE and Dnase1-deficient mice
Citation: Arthritis Research & Therapy 2000 3:66821 -
TNF-a suppresses CTGF expression
Citation: Arthritis Research & Therapy 2000 3:66820 -
Gene therapy that results in apoptosis of synovial fibroblasts
Citation: Arthritis Research & Therapy 2000 3:66819 -
Activation of the PTEN substrate PI3K contributes to tumour generation and autoimmunity
Citation: Arthritis Research & Therapy 2000 3:66818 -
What you should know about PR3-ANCA: Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA
The neutrophil azurophil granule constituent proteinase 3 (PR3) is the principal antigen for anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis. The conformation of the mature PR3 enzyme...
Citation: Arthritis Research & Therapy 2000 2:263 -
What you should know about PR3-ANCA: Evidence for the role of T cells in the pathogenesis of systemic vasculitis
The pathogenesis of systemic vasculitis is complex and is likely to involve many mechanisms. There is a growing body of evidence that T cells may contribute to the pathogenesis of anti-neutrophil cytoplasmic a...
Citation: Arthritis Research & Therapy 2000 2:260 -
What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3)
Reactive antigenic epitopes on presumed autoantigens of biologic interest have been examined by many researchers. The central third complementarity-determining region (CDR3) residues of a human monoclonal anti...
Citation: Arthritis Research & Therapy 2000 2:255 -
What you should know about PR3-ANCA: An introduction
Anti-neutrophil cytoplasmic antibodies (ANCA) have become important diagnostic markers of small vessel vasculitides characterized by focal necrotizing lesions of vessel walls and accumulation of lymphocytes an...
Citation: Arthritis Research & Therapy 2000 2:252 -
A clinical link between apoptosis and autoimmunity
Citation: Arthritis Research & Therapy 2000 2:66817 -
Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis
There is growing evidence that activated synovial fibroblasts, as part of a complex cellular network, play an important role in the pathogenesis of rheumatoid arthritis. In recent years, significant progress h...
Citation: Arthritis Research & Therapy 2000 2:361 -
Fibroblast biology Signals targeting the synovial fibroblast in arthritis
Fibroblast-like cells in the synovial lining (type B lining cells), stroma and pannus tissue are targeted by many signals, such as the following: ligands binding to cell surface receptors; lipid soluble, small...
Citation: Arthritis Research & Therapy 2000 2:348 -
Fibroblast biology Development and differentiation of synovial fibroblasts in arthritis
Synovial fibroblasts occur as two phenotypes - intimal and subintimal. The specialised intimal phenotype includes expression of uridine diphosphoglucose dehydrogenase (UDPGD), vascular cell adhesion molecule-1...
Citation: Arthritis Research & Therapy 2000 2:344 -
Fibroblast biology Synovial fibroblasts in rheumatoid arthritis: leading role or chorus line?
Citation: Arthritis Research & Therapy 2000 2:342 -
Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
Autoimmune diseases that are resistant to conventional treatment cause severe morbidity and even mortality. In the present study we demonstrate that complete remissions can be achieved in refractory polychondr...
Citation: Arthritis Research & Therapy 2000 2:327 -
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
The immunodominant T-cell epitope that is involved in collagen-induced arthritis (CIA) is the glycosylated type II collagen (CII) peptide 256-270. In CII transgenic mice, which express the immunodominant CII 2...
Citation: Arthritis Research & Therapy 2000 2:315 -
Immune ablation and stem-cell therapy in autoimmune disease: Experimental basis for autologous stem-cell transplantation
Treatment of rats suffering from florid chronic progressive systemic arthritis or from chronic remitting/relapsing encephalomyelitis with autologous bone marrow transplantation (BMT) is highly effective. This ...
Citation: Arthritis Research & Therapy 2000 2:281 -
Characterisation of LST1
Citation: Arthritis Research & Therapy 2000 2:66816 -
Regulation of synovial cell apoptosis by proteasome inhibitor
Citation: Arthritis Research & Therapy 2000 3:66815 -
Etanercept in children with polyarticular juvenile rheumatoid arthritis
Citation: Arthritis Research & Therapy 2000 2:66814 -
CD4 as a receptor for IL-16: To be or not to be?
Citation: Arthritis Research & Therapy 2000 3:66813 -
Chemokine receptor and cytokine profiles in juvenile arthritis
Citation: Arthritis Research & Therapy 2000 3:66812 -
Immune ablation and stem-cell therapy in autoimmune disease - Clinical experience
In the past 5 years, around 350 patients have received haematopoietic stem cell (HSC) transplantation for an autoimmune disease, with 275 of these registered in an international data base in Basel under the au...
Citation: Arthritis Research & Therapy 2000 2:276 -
Immune ablation and stem-cell therapy in autoimmune disease Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation
Studies on immunological reconstitution after immune ablation and stem-cell therapy may yield important clues to our understanding of the pathogenesis of human autoimmune disease, due to the profound effects o...
Citation: Arthritis Research & Therapy 2000 2:270 -
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
To determine whether IL-4 is therapeutic in treating established experimental arthritis, a recombinant adenovirus carrying the gene that encodes murine IL-4 (Ad-mIL-4) was used for periarticular injection into...
Citation: Arthritis Research & Therapy 2000 2:293 -
Immune ablation and stem-cell therapy in autoimmune disease Introduction
Citation: Arthritis Research & Therapy 2000 2:268 -
Citrullination: a small change for a protein with great consequences for rheumatoid arthritis
A new autoantibody activity, which is almost 100% specific for rheumatoid arthritis (RA), has been found. The essential part of the B-cell epitope is a modified form of arginine (ie citrulline). The conversion...
Citation: Arthritis Research & Therapy 2000 2:249 -
A transcription factor compelling Th1 differentiation
Citation: Arthritis Research & Therapy 2000 3:66811 -
IgVH genes from different anatomical regions, with different histopathological patterns, of a rheumatoid arthritis patient suggest cyclic re-entry of mature synovial B-cells in the hypermutation process
In the present study 55 IgVH genes amplified from three different anatomical regions of a rheumatoid arthritis (RA) patient were analyzed, adding further information on synovial B-cell maturation and recircula...
Citation: Arthritis Research & Therapy 2000 2:303 -
Physiologic role of interleukin-1 receptor antagonist
Recent studies have described the spontaneous development of arthritis or vasculitis in IL-1 receptor antagonist (IL-1Ra) knockout mice bred on specific and different genetic backgrounds. The levels of both se...
Citation: Arthritis Research & Therapy 2000 2:245 -
Tuning of T cell activation threshold
Citation: Arthritis Research & Therapy 2000 3:66810 -
The North American Rheumatoid Arthritis Consortium
Citation: Arthritis Research & Therapy 2000 2:0012 -
IL-1ra deficiency and atherosclerosis
Citation: Arthritis Research & Therapy 2000 3:66809 -
Implications of angiogenic heterogeneity
Citation: Arthritis Research & Therapy 2000 2:66808 -
Autoimmunity in IgM-deficient mice
Citation: Arthritis Research & Therapy 2000 3:66806